Core Laboratories N.V. (CLB) : Spectrum Asset Management (nbca) added new position in Core Laboratories N.V. during the most recent quarter end. The investment management firm now holds 9,690 shares of Core Laboratories N.V. which is valued at $1,116,579 , the company said in a statement filed on Aug 12, 2016 with the SEC.Core Laboratories N.V. makes up approximately 1.32% of Spectrum Asset Management (nbca)’s portfolio.
Other Hedge Funds, Including , Clinton Group Inc added CLB to its portfolio by purchasing 28,505 company shares during the most recent quarter which is valued at $3,284,631. Core Laboratories N.V. makes up approx 0.14% of Clinton Group Inc’s portfolio.K2 Principal Fund boosted its stake in CLB in the latest quarter, The investment management firm added 2,012 additional shares and now holds a total of 15,926 shares of Core Laboratories N.V. which is valued at $1,835,153. Core Laboratories N.V. makes up approx 0.43% of K2 Principal Fund’s portfolio. Bridgewater Associates Lp added CLB to its portfolio by purchasing 7,000 company shares during the most recent quarter which is valued at $806,610. Core Laboratories N.V. makes up approx 0.01% of Bridgewater Associates Lp’s portfolio.Montag Caldwell boosted its stake in CLB in the latest quarter, The investment management firm added 30 additional shares and now holds a total of 4,450 shares of Core Laboratories N.V. which is valued at $519,805. Core Laboratories N.V. makes up approx 0.01% of Montag Caldwell’s portfolio.
Core Laboratories N.V. closed down -0.29 points or -0.25% at $115.34 with 3,03,872 shares getting traded on Monday. Post opening the session at $115.07, the shares hit an intraday low of $114.5 and an intraday high of $116.1 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Core Laboratories N.V. reported $0.35 EPS for the quarter, based on the information available during the earnings call on Jul 20, 2016. Analyst had a consensus estimate of $0.35. The company had revenue of $148.10 million for the quarter, compared to analysts expectations of $146.21 million. The company’s revenue was down -27.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.81 EPS.
Many Wall Street Analysts have commented on Core Laboratories N.V.. JP Morgan Initiated Core Laboratories N.V. on Jun 10, 2016 to “Overweight”, Price Target of the shares are set at $120.
Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.